在红光照射下通过光还原触发RNA干扰
Jennifer Rühle1, Insa Klemt1, Andriy Mokhir1
1Department of Chemistry and Pharmacy, Organic Chemistry II, Friedrich-Alexander-University of Erlangen-Nürnberg (FAU), Nikolaus-Fiebiger Str. 10, 91058 Erlangen, Germany.
Molecules (Basel, Switzerland)
|May 27, 2023
概括
研究人员开发了一种新的红光可激活小干扰RNA (siRNA) 前药,用于癌症治疗. 这种改进的前药物避免了有毒的副产品和单片氧,为癌细胞中的向基因沉默提供了一种更安全的方法.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 与小干扰RNA (siRNA) 的RNA干扰 (RNAi) 是一个有前途的治疗策略.
- 目前的红光可激活siRNA预制药利用单片氧,该氧是细胞毒性,并产生有毒的副产品,如 antraquinone.
- 在体内癌症治疗中需要更安全,外部触发的siRNA激活.
研究的目的:
- 开发一种改进的红光可激活siRNA原药,可以绕过单点氧激活.
- 提高光激活siRNA治疗癌症治疗的安全性.
- 为了证明新型siRNA前药在体外和癌细胞中的红光诱导激活.
主要方法:
- 一种新型siRNA前药的设计和合成,该前药在反意义链的5'末端具有阿佐本促基.
- 红光照射在Sn ((IV) ((pyropheophorbide) a) 二化物催化剂和酸盐作为减少剂的存在下.
- 使用无细胞试验和人类卵巢癌A2780细胞确认前药激活.
主要成果:
- 这种新型阿佐基改性siRNA前药在暴露于红光时被激活,而不会产生单片氧.
- 激活机制涉及降低和分裂的亚博烯部分.
- 成功的红光诱导激活在无细胞条件下和在人类卵巢癌细胞内得到证实.
结论:
- 这项研究提出了一种新的,更安全的红光可激活siRNA原药,用于潜在的癌症治疗.
- 开发的前药物避免了与单片氧介导激活相关的有毒副作用.
- 这一进步为基于RNA干扰的癌症治疗提供了更有选择性和潜在的更少毒性的方法.
相关概念视频
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K
Transcriptional Regulation: Riboswitches
63
Riboswitches are RNA elements that regulate gene expression by altering their secondary structures in response to specific effector molecules. These elements, located in the leader regions of certain mRNAs, act as transcriptional regulators by toggling between alternative conformations to control downstream gene expression. Riboswitch-mediated regulation is a precise mechanism for modulating biosynthetic pathways, as exemplified by the riboflavin biosynthesis pathway in Bacillus...
63
Translational Regulation
46
Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
46
Types of RNA
5.9K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.9K
Riboswitches
8.2K
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
8.2K


